Shuyong Zhang
7PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Dec 01, 2025
A TROP2-targeting ADC synergizes with oxidative phosphorylation inhibitor to enhance apoptosis in ESCC by suppressing the PI3K-AKT-mTOR signaling pathway.Xinxin Liu, Jie Liu, Yi'an Zhou
|Mar 29, 2025
Antitumor activity of gilteritinib, an inhibitor of AXL, in human solid tumors.Zuxiong Zhang, Ruxia Hu, Jie Liu
|Apr 09, 2024
Combined therapy of dabrafenib and an anti-HER2 antibody-drug conjugate for advanced BRAF-mutant melanoma.Weisong Li, Chao Zheng, Xi Xu
|Mar 05, 2024
Synergistic antitumor activity between HER2 antibody-drug conjugate and chemotherapy for treating advanced colorectal cancer.Hongfu Liu, Dongdong Zhou, Dongqin Liu
|Feb 25, 2024
Combined inhibition of HER2 and VEGFR synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer.Weisong Li, Kai Zhang, Wenjun Wang
|Jan 18, 2024
The P286R mutation of DNA polymerase ε activates cancer-cell-intrinsic immunity and suppresses endometrial tumorigenesis via the cGAS-STING pathway.Ming Tang, Shasha Yin, Hongliang Zeng
Pageof 2
